These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16540213

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T, Watanabe I, Tao E, Ito S, Kawaguchi A, Tamura S, Takahashi H, Sawa H, Moriyama M, Chiba J, Komase K, Suzuki Y, Kurata T, Sata T, Hasegawa H.
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [Abstract] [Full Text] [Related]

  • 24. Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine.
    Hagenaars N, Mania M, de Jong P, Que I, Nieuwland R, Slütter B, Glansbeek H, Heldens J, van den Bosch H, Löwik C, Kaijzel E, Mastrobattista E, Jiskoot W.
    J Control Release; 2010 May 21; 144(1):17-24. PubMed ID: 20100528
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A sheep cannulation model for evaluation of nasal vaccine delivery.
    Yen HH, Scheerlinck JP, Gekas S, Sutton P.
    Methods; 2006 Feb 21; 38(2):117-23. PubMed ID: 16414273
    [Abstract] [Full Text] [Related]

  • 27. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N, Mastrobattista E, Glansbeek H, Heldens J, van den Bosch H, Schijns V, Betbeder D, Vromans H, Jiskoot W.
    Vaccine; 2008 Dec 02; 26(51):6555-63. PubMed ID: 18848856
    [Abstract] [Full Text] [Related]

  • 28. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
    Okamoto S, Matsuura M, Akagi T, Akashi M, Tanimoto T, Ishikawa T, Takahashi M, Yamanishi K, Mori Y.
    Vaccine; 2009 Sep 25; 27(42):5896-905. PubMed ID: 19647814
    [Abstract] [Full Text] [Related]

  • 29. The role of adjuvants in vaccines for seasonal and pandemic influenza.
    Brown LE.
    Vaccine; 2010 Nov 23; 28(50):8043-5. PubMed ID: 20849874
    [Abstract] [Full Text] [Related]

  • 30. Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice.
    Song SK, Moldoveanu Z, Nguyen HH, Kim EH, Choi KY, Kim JB, Mestecky J.
    Vaccine; 2007 Aug 21; 25(34):6359-66. PubMed ID: 17640781
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.
    Skene CD, Doidge C, Sutton P.
    Vaccine; 2008 Jul 23; 26(31):3880-4. PubMed ID: 18547687
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
    Powers DC, Murphy BR, Fries LF, Adler WH, Clements ML.
    J Am Geriatr Soc; 1992 Feb 23; 40(2):163-7. PubMed ID: 1740601
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.
    Ansaldi F, Bacilieri S, Durando P, Sticchi L, Valle L, Montomoli E, Icardi G, Gasparini R, Crovari P.
    Vaccine; 2008 Mar 17; 26(12):1525-9. PubMed ID: 18294741
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G, Greenbaum E, Zakay-Rones Z.
    Isr Med Assoc J; 2006 Mar 17; 8(3):155-8. PubMed ID: 16599048
    [Abstract] [Full Text] [Related]

  • 39. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L, Geeraedts F, Ter Veer W, Medema J, Wilschut J, Huckriede A.
    Vaccine; 2008 May 02; 26(19):2350-9. PubMed ID: 18400340
    [Abstract] [Full Text] [Related]

  • 40. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J.
    J Med Virol; 2007 Mar 02; 79(3):320-5. PubMed ID: 17245715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.